Amgen’s Xgeva cleared for multiple myeloma patients
admin 8th January 2018 Uncategorised 0US regulators have expanded the scope of Amgen’s Xgeva to include the prevention of skeletal-related events in patients with multiple myeloma.
More: Amgen’s Xgeva cleared for multiple myeloma patients
Source: News